PF4/Heparin Antibodies Predict Mortality in HIT

This article originally appeared here.
Share this content:
PF4/Heparin Antibodies Predict Mortality in HIT
PF4/Heparin Antibodies Predict Mortality in HIT

MONDAY, Jan. 11, 2016 (HealthDay News) -- Heparin-induced thrombocytopenia (HIT) is infrequent in patients undergoing cardiac surgery, but is associated with increased 30-day mortality, according to a study published in the Jan. 15 issue of The American Journal of Cardiology.

Xiumei Sun, M.D., from the Medstar Heart Institute in Washington, D.C., and colleagues examined the impact of HIT on contemporary cardiac surgical practice. A total of 14,415 consecutive patients undergoing cardiac surgery were screened postoperatively for thrombocytopenia. Those with thrombocytopenia were tested for antiplatelet factor 4 (PF4)/heparin antibodies and assessed for clinical evidence of thrombosis.

The researchers found that 13 percent of the patients had thrombocytopenia. Of these, 15 and 4 percent had PF4/heparin antibodies and antibodies and clinical thrombosis, respectively. The frequency of antibodies was elevated in women (P = 0.01), in patients with increased body mass index (P < 0.01), and in patients with preoperative clinical heart failure (P < 0.01). Among the 76 patients with the triad of thrombocytopenia, antibodies, and clinical thrombosis, 30-day mortality was highest (30 percent). The presence of PF4/heparin antibodies independently predicted 30-day mortality among patients with thrombocytopenia (odds ratio, 2.09; P < 0.001).

"HIT remains an infrequent but very serious complication of heparin therapy in contemporary cardiac surgical practice," the authors write. "The possibility that the presence of HIT antibodies in patients with thrombocytopenia independently increases operative mortality deserves further study."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

Congress Approves Bill Expanding Private Care for VA Patients

Congress Approves Bill Expanding Private Care for VA ...

New bill would open up access to private doctors for veterans

AAP Recommending Injectable Flu Shot for 2018-19 Flu Season

AAP Recommending Injectable Flu Shot for 2018-19 Flu ...

Children should receive injectable vaccine, which has been shown to be more consistently effective

Neurologists Identify New Type of Vertigo

Neurologists Identify New Type of Vertigo

Long-term prognosis favorable, with improvement of symptoms in more than half of patients